SS-31

SS-31, also known as elamipretide, is a synthetic tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2. Unlike many other peptides that work on surface receptors, SS-31 was engineered to specifically target the mitochondria — the energy-producing organelles inside cells.

What makes SS-31 unique is its high affinity for cardiolipin, a phospholipid found in the inner mitochondrial membrane that is essential for maintaining mitochondrial structure and energy production. By binding directly to cardiolipin, SS-31 protects the integrity of the mitochondrial membrane and helps optimize cellular energy output.

Key characteristics of SS-31 include:

→ Mitochondria-targeted design – built to accumulate inside the mitochondria where energy metabolism and oxidative stress occur.
→ Stabilizes cardiolipin – preserves mitochondrial membrane integrity and electron transport chain function.
→ Improves bioenergetics – enhances ATP production, the body’s primary energy currency.
→ Synthetic and stable – unlike naturally occurring peptides such as Humanin or MOTS-c, SS-31 was engineered for therapeutic use, with stability and bioavailability in mind.

Originally developed in the early 2000s, SS-31 has been investigated for its role in treating age-related diseases, heart failure, and mitochondrial disorders. More recently, it has gained interest in the longevity, recovery, and performance space due to its ability to restore mitochondrial function and reduce oxidative damage at the cellular level.

---

Mechanism of Action: How SS-31 Works

The power of SS-31 lies in its direct targeting of mitochondria, making it one of the few peptides that works inside the cell’s energy center rather than on surface receptors. Its actions revolve around protecting and optimizing mitochondrial function, which influences energy, recovery, and cellular health.

1. Cardiolipin Binding

→ SS-31 has a strong affinity for cardiolipin, a phospholipid unique to the inner mitochondrial membrane.
→ Cardiolipin is critical for maintaining mitochondrial structure and supporting the electron transport chain.
→ By binding to cardiolipin, SS-31 stabilizes the mitochondrial membrane and prevents structural damage.

2. Improves Electron Transport Efficiency

→ The electron transport chain (ETC) is where ATP, the body’s energy currency, is produced.
→ SS-31 optimizes the interactions within the ETC, reducing electron “leakage” that causes inefficiency.
→ This leads to improved ATP production and greater energy availability at the cellular level.

3. Reduces Oxidative Stress

→ Inefficient mitochondria produce excessive reactive oxygen species (ROS), which damage DNA, proteins, and lipids.
→ By stabilizing the ETC and cardiolipin, SS-31 reduces ROS generation at the source.
→ This limits oxidative stress and protects surrounding tissues from chronic inflammation and aging.

4. Enhances Cellular Bioenergetics

→ Increases the overall output of ATP, giving cells more energy to perform vital processes.
→ Supports tissues with high energy demand, including the heart, brain, skeletal muscle, and nervous system.
→ May improve endurance, recovery, and resistance to fatigue.

5. Protects Against Mitochondrial Dysfunction

→ Mitochondrial decline is linked to aging, neurodegenerative diseases, and metabolic disorders.
→ SS-31 preserves mitochondrial function even under stress, making it a potential therapeutic tool in both medicine and performance applications.

---

Benefits of SS-31 Peptide

SS-31 has been studied for its ability to restore mitochondrial health, protect cells from damage, and improve energy production. These effects make it valuable not only in clinical research but also in potential applications for recovery, performance, and longevity.

1. Mitochondrial Protection

→ Stabilizes cardiolipin and preserves mitochondrial structure.
→ Shields cells from dysfunction caused by aging, stress, or disease.
→ Maintains the integrity of energy production systems over time.

Russo, Scientific Reports

2. Improved Cellular Energy

→ Enhances ATP output in tissues with high energy demand, such as muscle and heart.
→ Supports faster recovery from physical exertion.
→ May improve stamina and reduce fatigue during prolonged activity.

3. Reduced Oxidative Stress

→ Lowers the production of harmful free radicals within mitochondria.
→ Limits DNA, protein, and lipid damage linked to aging.
→ Reduces systemic inflammation driven by oxidative stress.

4. Neuroprotective Effects

→ Protects neurons from mitochondrial dysfunction.
→ Supports memory, focus, and overall brain health.
→ May slow cellular decline associated with age-related cognitive loss.

5. Muscle Recovery and Endurance

→ Improves muscle bioenergetics and oxygen utilization.
→ May help reduce exercise-induced fatigue.
→ Enhances recovery between training sessions or intense bouts of activity.

6. Anti-Aging Potential

→ Counters one of the root causes of aging: mitochondrial decline.
→ Promotes healthier cellular metabolism across multiple organs.
→ May delay age-related deterioration in performance, vitality, and resilience.

---

SS-31 Dosage And Application

SS-31 is distinct from many peptides because it is designed for mitochondrial targeting and is not typically delivered in topical or oral forms. Most applications in research have used injections, with dosing protocols varying depending on study design.

Method of Administration

→ Primarily delivered via subcutaneous injection, allowing the peptide to circulate and reach tissues efficiently.
→ Some studies have also explored intravenous administration for clinical applications, particularly in mitochondrial disease and cardiac conditions.

Typical Dosing Ranges

→ Research settings often use daily or every-other-day injections.
→ Dosage varies depending on the condition studied, but ranges in human trials have generally fallen within the single-digit milligram scale per day.
→ Since SS-31 is not FDA-approved, there are no standardized clinical dosing guidelines outside of investigational studies.